PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-Feb-2020 Sobi Publishes Report for the Fourth Quarter and Full-year 2019 Swedish Orphan Biovitrum AB
12-Feb-2020 Akorn Announces New Extension of Standstill with Lenders and Agrees to Pursue a Sale of its Business Akorn, Inc.
12-Feb-2020 CTMA presents results from clinical trial pre-screening digital solution at ECCO 2020 Clinical Trials Mobile Application (CTMA)
12-Feb-2020 Conference Chair from AstraZeneca invites you to attend Pre-filled Syringes East Coast 2020 SMi Group
12-Feb-2020 Antios Therapeutics Initiates First-in-Human Phase I Study of ATI-2173 Antios Therapeutics, Inc.
12-Feb-2020 Leading Alzheimer's Disease Experts Join T3D Therapeutics' Scientific Advisory Board T3d Therapeutics, Inc.
12-Feb-2020 4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain 4SC AG
11-Feb-2020 AI in Drug Discovery to host panel discussion on “The AI Paradigm Shift – is it just a hype?” SMi Group
11-Feb-2020 IBBR Request for Proposals (RFP): GMP Biomanufacturing Facility Available - Rockville, Maryland, USA Institute for Bioscience and Biotechnology Research
11-Feb-2020 TriNetX Unveils Turnkey Protocol & Site Feasibility Service Offering TriNetX
11-Feb-2020 CytRx Corporation Highlights Recently Published Data of its Licensee Orphazyme A/S Phase 2 Trial of Arimoclomol in the Treatment of Sporadic Inclusion Body Myositis (sIBM) CytRx Corporation
11-Feb-2020 Biotech Brief: Global Diabetes Drug Market Could Reach $78 Billion By End Of 2026 FinancialNewsMedia.com
11-Feb-2020 Valgenesis To Digitize Validation Processes Across Multiple Sites For A Global Contract Development And Manufacturing Organization (CDMO) Based In Southern Europe ValGenesis, Inc.
11-Feb-2020 Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal Cancers Cannabics Pharmaceuticals Inc.
11-Feb-2020 OncoSec Strengthens its Board of Directors with Three New Appointments OncoSec Medical Incorporated
11-Feb-2020 Stilla Technologies raises EUR20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones Stilla Technologies
11-Feb-2020 AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference AbbVie
11-Feb-2020 BD Completes Clinical Trial for BD Libertas™ Wearable Injector B3C newswire
11-Feb-2020 Medivir Invites to R&D Day on March 2, 2020 Medivir
10-Feb-2020 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2020 Ended December 31, 2019 and Provides Conference Call Information Elite Pharmaceuticals, Inc.